Nicardipine for the treatment of severe hypertension in pregnancy: A review of the literature

Obstetrical and Gynecological Survey

Volumn 65, Issue 5, 2010, Pages 341-347

  Bijvank, Sebastiaan W A Nij ^a   Duvekot, Johannes J ^b  

^a ISALA HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; DIGOXIN; DIHYDRALAZINE; KETANSERIN; LABETALOL; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; URAPIDIL; ANTIHYPERTENSIVE AGENT;

ACIDOSIS; BLOOD PRESSURE REGULATION; BRADYCARDIA; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; FEMALE; FETUS DEATH; FLUSHING; HUMAN; HYPERCAPNIA; HYPOTENSION; HYPOXEMIA; LUNG EDEMA; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; NAUSEA AND VOMITING; PERIPHERAL EDEMA; PREGNANCY; PREMATURE LABOR; PROTEINURIA; REVIEW; SIDE EFFECT; SINUS BRADYCARDIA; SMALL FOR DATE INFANT; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VASODILATATION; HYPERTENSION, PREGNANCY-INDUCED; LITERATURE; SEVERITY OF ILLNESS INDEX;

ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; NICARDIPINE; PREGNANCY; REVIEW LITERATURE AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77954323375     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181e2c795     Document Type: Review

References (40)

1. Rey E, LeLorier J, Burgess E, et al. Report of the Canadian Hypertension Society Consensus Conference: part 3. Pharmacologic treatment of hypertension disorders in pregnancy. CMAJ 1997;157:1245-1254.
2. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:1-22.
3. Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: metaanalysis. BMJ 2003;327:955-960.
4. Stevens TP, Guillet R. Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy. J Pediatr 1995;127:151-153.
5. Haraldsson A, Geven W. Severe adverse effects of maternal labetalol in premature infant. Acta Paediatr Scand 1989;78:956-958. (Pubitemid 20011711)
6. Olsen KS, Neier-Holmersen R. Fetal death following labetalol administration in preeclampsia. Acta Obstet Gynecol Scand 1992;71:145-147.
7. Mabie WC, Gonzalez AR, Sibai BM, et al. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987;70:328-333.
8. Duley L, Henserson-Smart DJ. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2002: CD001449.
9. Nij Bijvank SW, van Heusden A. Torsades de Pointes in a young pregnant woman with pre-eclampsia and the role of ketanserin. Ned Tijdschr Obstet Gynaecol 2004;2:6-8.
10. Ulmsten U, Anderson KE, Wingerup L. Treatment of premature labor with the calcium antagonist nifedipine. Arch Gynecol 1980;229:1-5.
11. King JF, Flenady VJ, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003: CD002255.
12. Ulmsten U. Treatment of normotensive and hypertensive patients with pre-term labor using oral nifedipine, a calcium antagonist. Arch Gynecol 1984;236:69-72.
13. Walters BN, Redman CW. Treatment of severe pregnancy associated hypertension with the calcium antagonist nifedipine. Br J Obstet Gynaecol 1984;91:330-336.
14. van Geijn HP, Lenglet JE, Bolte AC. Nifedipine trials: effectiveness and safety aspects. Br J Obstet Gynaecol 2005;112:79-83.
15. Wallin JD, Cook ME, Blanski L, et al. Intravenous nicardipine for the treatment of severe hypertension. Am J Med 1988;85:331-338.
16. Clinical Experience in Hypertension, Stable Angina and Per (I) - Operative Hypertension [product monograph]. Brussels, Belgium: Yamanouchi Pharma B. V. 1999.
17. Bristow MR, Ginsburg R, Laser JA, et al. Tissue response selectivity of calcium antagonists is not due to heterogeneity of 3H-nitrendipine binding sites. Br J Pharmacol 1984;82:309-320.
18. Ducsay CA, Thompson JS, Wu AT, et al. Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: fetal plasma concentrations and cardiorespiratory changes. Am J Obstet Gynecol 1987;157:1482-1486.
19. Carbonne B, Jannet D, Touboul C, et al. Nicardipine treatment of hypertension during pregnancy. Obstet Gynecol 1993;81:908-914.
20. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest 2000;118:214-227.
21. Hanff LM, Vulto AG, Bartels PA, et al. Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients. J Hypertens 2005;23:2319-2326.
22. Elatrous S, Nouira S, Ouanes Besbes L, et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Intensive Care Med 2002;28:1281-1286.
23. Dubois C, Blanchard D. Efficacy and safety of nicardipine in 29, 104 patients with hypertension. Clin Ther 1989;11:452-460.
24. IV Nicardipine Study Group. Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. Chest 1991;99:393-398.
25. Arima H, Sobue K, Tanaka S, et al. Profound sinus bradycardia after intravenous nicardipine. Anesth Analg 2002;95:53-55.
26. Vaast P, Dubreucq-Fossaert S, Houfflin-Debarge V, et al. Acute pulmonary edema during nicardipine therapy for premature labour: report of five cases. Eur J Obstet Gynecol Reprod Biol 2004;113:98-99.
27. Bal L, Thierry S, Brocas E, et al. Pulmonary edema induced by calcium-channel blockade for tocolysis. Anesth Analg 2004;99:910-911.
28. Parisi VM, Salinas J, Stockmar EJ. Fetal vascular response to maternal nicardipine administration in the hypertensive ewe. Am J Obstet Gynecol 1989;161:1035-1039. (Pubitemid 19266227)
29. Parisi VM, Salinas J, Stockmar EJ. Placental vascular response to nicardipine in the hypertensive ewe. Am J Obstet Gynecol 1989;161:1039-1043.
30. Seki H, Takeda S, Kinoshita K. Long-term treatment with nicardipine for severe pre-eclampsia. Int J Gynaecol Obstet 2002;76:135-141.
31. Aya AG, Mangin R, Hoffet M, et al. Intravenous nicardipine for severe hypertension in pre-eclampsie: effects of an acute treatment on mother and fetus. Intensive Care Med 1999;25:1277-1281.
32. Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983;61:571-576.
33. Constantine G, Beevers DG, Reynolds AL, et al. Nifedipine as a second line antihypertensive drug in pregnancy. Br J Obstet Gynaecol 1987;94:1136-1142.
34. Seabe SJ, Moodley J, Becker P. Nifedipine in acute hypertension emergencies in pregnancy. S Afr Med J 1989;76:248-250.
35. Fenakel K, Fenakel G, Appelman Z, et al. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991;77:331-337.
36. Sibai BM, Barton JR, Akl S, et al. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 1992;167:879-884.
37. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-1463.
38. Lu JF, Nightingale CH. Magnesium Sulfate in eclampsia and pre-eclampsia, pharmocokinetic principles. Clin Pharmacokinet 2000;38:305-314.
39. Waisman GD, Mayorga LM, Camera MI, et al. Magnesium plus nifedipine: potentation of hypotensive effect in preeclampsia? Am J Obstet Gynecol 1988;159:308-309.
40. Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 1994;101:262-263.